Histiocytic Necrotizing Lymphadenitis with Cupriavidus Pauculus Infection in a Patient with Graves Hyperthyroidism: A Case Report
Shan Tian,Bin Zhu,Youyou Tian,Junyuan Li,Cheng Peng
DOI: https://doi.org/10.2147/IDR.S349655
2022-03-10
Infection and Drug Resistance
Abstract:Shan Tian, 1, &ast Bin Zhu, 1, &ast Youyou Tian, 2 Junyuan Li, 1 Cheng Peng 1 1 Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, People's Republic of China; 2 Department of Infectious Diseases, Taihe Hospital, Hubei Medical University, Shiyan, 442000, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Cheng Peng, Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei, People's Republic of China, Email Histiocytic necrotizing lymphadenitis (HNL) is a self-limiting inflammatory disease presenting with fever and cervical lymphadenopathy. However, no case of HNL with confirmed bacterial infection has been reported. A 38-year-old man was admitted to our hospital owing to an intermittent fever from 8 days. He was diagnosed with Graves hyperthyroidism 3 months prior and began taking methimazole tablets orally. Physical examination revealed superficial lymphadenopathy and goiter of the thyroid (grade II). Blood routine showed a decrease in peripheral blood cells, including significant reduction in leukocytes and platelets. A bone marrow culture identified a very rare pathogen, Cupriavidus pauculus , but the antibiotic effect of meropenem was unsatisfactory. Biopsy of the left cervical lymph node revealed HNL, and the patient had no fever after using glucocorticoids. This case report indicates that clinicians should be aware of the coexistence of HNL and bacterial infections, especially in patients with Graves hyperthyroidism. Keywords: histiocytic necrotizing lymphadenitis, leucopenia, Graves hyperthyroidism, Cupriavidus pauculus , glucocorticoid Histiocytic necrotizing lymphadenitis (HNL) is a reactive proliferative disease in the lymph nodes, which is not common in clinical settings. 1 Previous literature reported that this disease has a recurrence rate of 3.5%, and 1.7% of individuals pass from untimely treatment or serious complications. 2 The disease commonly occurs in young patients under the age of 40 and is characterized by high fever and chills. Some patients may have superficial lymphadenopathy and hepatosplenomegaly, and a few patients may experience local skin rashes. This rare disease has been reported in patients with connective tissue diseases, such as systemic lupus erythematosus or rheumatoid arthritis, but has never been reported in individuals with Graves hyperthyroidism. Herein, we describe a young patient with HNL secondary to Graves hyperthyroidism. Notably, this patient was infected with a very rare pathogen, Cupriavidus pauculus . A 38-year-old man was admitted to the Department of Infectious Diseases, Wuhan Union Hospital on July 19, 2021, with the chief complaint of intermittent fever for 8 days. On day 1 of symptom presentation, the patient experienced a fever as high as 40 °C without an obvious cause of fever, accompanied by headache, sore throat, fatigue discomfort, and diarrhea (4–5 times per day). He visited the local hospital, and his blood routine examination showed leucopenia. His body temperature returned to normal and frequency of diarrhea was reduced after anti-infection treatment. He visited the local hospital again for the recurrence of fever on day 7. No obvious infectious lesions were observed on his chest computed tomography (CT). Blood routine showed low levels of leukocytes (0.87 G/L, range:3.5–9.5 G/L), platelets (14 G/L, range:125–350 G/L), hemoglobin (99 g/L, range: 115–150 g/L), and high levels of C-reactive protein (CRP) (151.86 mg/L, range:<8.0 mg/L). However, there was no relief of symptoms after combined therapy with antibiotics, elevation of white blood cells, and platelets (specific drugs are not available). Therefore, he went to the infection department of Wuhan Union Hospital for further treatment on day 8. During the course of fever, he exhibited sleeplessness and poor appetite. Three months ago, the patient was diagnosed with Graves hyperthyroidism in the external hospital, and was treated with oral methimazole (10 mg, two tablets each in the morning and evening). Blood routine plus reticulocyte revealed reduction of the ternary systems (white blood cell count of 0.68 G/L (range: 3.5–9.5 G/L), red blood cell count of 3.29 T/L (range:3.8–5.1, T/L), hemoglobin of 92 g/L (range:115–150 g/L), and platelet count of 26 G/L, range:125–350 G/L), and myelosuppression (reticulocyte percentage of 0.26%, range:0.5%-1.5%, reticulocyte count of 0.01 G/L, range:0.024–0.084). Thyroid function examination identified hyperthyroidism (FT4: 24.7 pmol/L, range:9–19.8 pm -Abstract Truncated-
pharmacology & pharmacy,infectious diseases